Navigation Links
CLAAD Selects Egalet As Top Five Technologies To Reduce Prescription Drug Abuse Honoree
Date:11/27/2012

WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) today recognized Egalet Ltd., a specialty pharmaceutical company focused on developing safe, effective, and tamper-resistant medications, as a Top Five Technologies To Reduce Prescription Drug Abuse honoree.

Egalet is developing a pipeline of tamper-resistant opioids that are nearing pivotal testing.

Roland Gerritsen van der Hoop, Chief Medical Officer of Egalet, received the award on behalf of the company during the National Prescription Drug Abuse Prevention Policy Consensus Meeting in Washington, DC.

"We are honored to be recognized by CLAAD for our efforts to bring to market abuse-resistant opioids," said Bob Radie, CEO and president of Egalet. "We believe our erosion-based delivery technology will help improve the safe delivery of opioids."

The Top 5 Technologies competition aims to increase public awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.

Michael Barnes, spokesman for CLAAD, stated, "We are pleased to honor Egalet for its work to develop pharmaceutical products that are less susceptible to tampering and abuse."

San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest. Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.

"We are proud to recognize Egalet for joining Millennium and CLAAD in our efforts to advance patient care and reduce prescription drug abuse," said Howard Appel, President of Millennium Laboratories. 

About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is a national coalition of health care providers, law enforcement, community organizations, and businesses working together to reduce prescription drug abuse while optimizing patient care. Visit claad.org, and follow @claad_coalition

About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety. 

About Egalet Ltd.
Egalet Ltd. is a specialty pharmaceutical company using patented technology to produce a pipeline of tamper-resistant opioids that are nearing pivotal testing.  Egalet has pioneered one of the world's first erosion-based delivery technologies to enable the controlled release of medications through gradual erosion of a tablet.  


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CLAAD Warns of Increase in Prescription Drug Overdoses
2. CLAAD Names Eagle Advancement Institute as Honoree of Top 5 Technologies To Reduce Prescription Drug Abuse
3. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
4. CLAAD Recognizes SMART/Script as Top 5 Technology To Reduce Rx Abuse
5. CLAAD Recognizes The Locking Cap as Top 5 Technology To Reduce Rx Abuse
6. Angeion Selects Hendrik Struik for Board of Directors
7. PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor
8. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
9. ZyDoc Selects Health Fidelitys REVEAL™ Natural Language Processing (NLP) Platform to Accelerate Time to Value for its MediSapien Web Services
10. Pokagon Band of Potawatomi selects iSALUS Healthcares OfficeEMR™ Solution
11. ICON Medical Imaging Selects AG Mednet to Give Clinical Trial Sponsors Zero-Delay Efficiency and Faster Decision-Making Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... , Sept. 7, 2017  For nearly two decades, New Life Agency ... Assisted Reproduction Insurance industry. Today, New Life Agency announces a powerful three-way ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)... Sept. 7, 2017 NuvoAir (formerly called ... announced today a partnership with Novartis Pharma AG to distribute ... position as the leading mobile spirometry platform and Novartis, commitment ... ... ...
(Date:9/7/2017)... 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting at ... Rodman & Renshaw 19 th Annual Global Investment Conference ... p.m. Pacific time). The conference is being held at the ...
Breaking Medicine Technology:
(Date:9/25/2017)... VA (PRWEB) , ... September 25, 2017 , ... ... and Response Preconference Workshop, **Presented by FDAnews**, Nov. 1-3, 2017 – Bethesda, MD, ... drugmaker passed with flying colors. And then, on the tenth inspection it failed. ...
(Date:9/24/2017)... (PRWEB) , ... September 25, 2017 , ... Bhowanie Benimadhu’s ... iUniverse) explores the fundamental questions of life and seeks answers in both Eastern and ... , “The searching for God is in the mind of humankind for the past ...
(Date:9/24/2017)... , ... September 23, 2017 , ... Throughout the United ... harm. , Every day, physicians, nurses and other providers work to give the ... innovative industry processes. , But U.S. Senators today are threatening to tie our ...
(Date:9/24/2017)... ... ... Messiah 8 with the 3rd Anti Christ”: a forceful and dynamic narrative that ... Anti Christ” is the creation of published author, Albert Velazquez. , “It ... Velazquez states, “I always come to the same conclusion: God loves working in mysterious ...
(Date:9/24/2017)... ... ... “The Gospel Truth Of The Bible: The Other Sheep”: the ceremonial laws of Moses and ... Sheep” is the creation of published author, Maurice Caines. Maurice Caines resides in the ... been a member of the Seventh-day Adventist Church for many years. He was previously ...
Breaking Medicine News(10 mins):